Publications

Home » Publications
Export 32 results:
Filters: Author is Oldenburg, Catherine E  [Clear All Filters]
2024
O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM et al..  2024.  Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.. N Engl J Med. 391(8):699-709.
Doan T, Liu Z, Sie A, Dah C, Bountogo M, Ouattara M, Coulibaly B, Kiemde D, Zonou G, Nebie E et al..  2024.  Gut Microbiome Diversity and Antimicrobial Resistance After a Single Dose of Oral Azithromycin in Children: A Randomized Placebo-Controlled Trial.. Am J Trop Med Hyg.
Oldenburg CE, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Compaoré G, Dah C, Zakane A, Coulibaly B, Bagagnan C et al..  2024.  Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.. JAMA. 331(6):482-490.
Bountogo M, Ouermi L, Dah C, Sie A, Coulibaly B, Zakane A, Ouedraogo T, Ouattara M, Lebas E, Fetterman I et al..  2024.  Neonatal Azithromycin Exposure and Childhood Growth: Long-Term Follow-Up of a Randomized Controlled Trial.. Am J Trop Med Hyg.
Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.
Amza A, Kadri B, Nassirou B, Arzika A, Gebreegziabher E, Hu H, Zhong L, Chen C, Yu D, Abraham T et al..  2024.  Seroepidemiology of trachoma in a low prevalence region receiving annual mass azithromycin distribution in Maradi, Niger.. PLoS Negl Trop Dis. 18(12):e0012727.
2022
Arzika AM, Maliki R, E Goodhew B, Rogier E, Priest JW, Lebas E, O'Brien KS, Le V, Oldenburg CE, Doan T et al..  2022.  Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.. Nat Commun. 13(1):976.
Coulibaly B, Kiemde D, Zonou G, Sie A, Dah C, Bountogo M, Brogdon J, Hu H, Lebas E, Porco TC et al..  2022.  Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial.. Pediatr Infect Dis J. 41(9):728-730.
Oldenburg CE, Hinterwirth A, Dah C, Millogo O, Coulibaly B, Ouédraogo M, Sie A, Chen C, Zhong L, Ruder K et al..  2022.  Gut Microbiome among Children with Uncomplicated Severe Acute Malnutrition in a Randomized Controlled Trial of Azithromycin versus Amoxicillin.. Am J Trop Med Hyg.
Oldenburg CE, Hinterwirth A, Ourohiré M, Dah C, Ouédraogo M, Sie A, Boudo V, Chen C, Ruder K, Zhong L et al..  2022.  Gut Resistome after Antibiotics among Children with Uncomplicated Severe Acute Malnutrition: A Randomized Controlled Trial.. Am J Trop Med Hyg. 107(1):59-64.
Oldenburg CE, Sie A, Bountogo M, Zakane A, Compaoré G, Ouedraogo T, Koueta F, Lebas E, Brogdon J, Nyatigo F et al..  2022.  Neonatal azithromycin administration for prevention of infant mortality.. NEJM Evid. 1(4):EVIDoa2100054.
2021
O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.
Coulibaly B, Sie A, Dah C, Bountogo M, Ouattara M, Compaoré A, Nikiema M, Tiansi JNankoné, Sibiri NDembélé, Brogdon JM et al..  2021.  Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial.. Malar J. 20(1):360.
Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L, Nyatigo F, Cook CA, Hinterwirth A, Lebas E et al..  2021.  Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.. JAMA.
Arzika AM, Maliki R, Abdou A, Mankara AK, Harouna AN, Cook C, Hinterwirth A, Worden L, Zhong L, Chen C et al..  2021.  Gut resistome of preschool children after prolonged mass azithromycin distribution: a cluster-randomized trial.. Clin Infect Dis.
Brogdon JM, Sie A, N Dah C, Ouermi L, Coulibaly B, Lebas E, Zhong L, Chen C, Lietman TM, Keenan JD et al..  2021.  Poultry Ownership and Genetic Antibiotic Resistance Determinants in the Gut of Preschool Children.. Am J Trop Med Hyg.
Sie A, Coulibaly B, Dah C, Bountogo M, Ouattara M, Compaoré G, Brogdon JM, Godwin WW, Lebas E, Doan T et al..  2021.  Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial.. BMC Pediatr. 21(1):130.
2020
Sie A, Dah C, Bountogo M, Ouattara M, Nebie E, Coulibaly B, Brogdon JM, Godwin WW, Lebas E, Doan T et al..  2020.  Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial.. Am J Trop Med Hyg.
Oldenburg CE, Doan T.  2020.  Azithromycin for severe COVID-19.. Lancet. 396(10256):936-937.
Digitale J, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Lebas E, Arzika AM, Glymour MMaria et al..  2020.  Gut Bacterial Diversity and Growth among Preschool Children in Burkina Faso.. Am J Trop Med Hyg. 103(6):2568-2573.
Oldenburg CE, Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Cummings SL, Zhong L, Chen C et al..  2020.  Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized, Controlled Trial.. Clin Infect Dis. 70(3):525-527.
Oldenburg CE, Hinterwirth A, Worden L, Sie A, Dah C, Ouermi L, Coulibaly B, Zhong L, Chen C, Ruder K et al..  2020.  Indirect effect of oral azithromycin on the gut resistome of untreated children: a randomized controlled trial.. Int Health.
Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.
Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Zhong L, Chen C, Lietman TM, Keenan JD et al..  2020.  Rapid Reduction of Species in the Gut Microbiome of Preschool Children after Oral Azithromycin: A Randomized Controlled Trial.. Am J Trop Med Hyg. 103(3):1266-1269.
Doan T, Hinterwirth A, Arzika AM, Worden L, Chen C, Zhong L, Oldenburg CE, Keenan JD, Lietman TM.  2020.  Reduction of Coronavirus Burden With Mass Azithromycin Distribution.. Clin Infect Dis. 71(16):2282-2284.
Oldenburg CE, Doan T.  2020.  Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.. Am J Trop Med Hyg. 102(6):1154-1155.
2019
Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.
Oldenburg CE, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Lebas E, Arzika AM, Cummings S et al..  2019.  Indirect Effect of Azithromycin Use on the Intestinal Microbiome Diversity of Untreated Children: A Randomized Trial.. Open Forum Infect Dis. 6(3):ofz061.
Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.
Sie A, Bountogo M, Nebie E, Ouattara M, Coulibaly B, Bagagnan C, Zabre P, Lebas E, Brogdon J, Godwin WW et al..  2019.  Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.. BMJ Open. 9(9):e031162.
2018
Oldenburg CE, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Ray KJ, Zhong L, Cummings S et al..  2018.  Effect of Commonly Used Pediatric Antibiotics on Gut Microbial Diversity in Preschool Children in Burkina Faso: A Randomized Clinical Trial.. Open Forum Infect Dis. 5(11):ofy289.
Doan T, Hinterwirth A, Arzika AM, Cotter SY, Ray KJ, O'Brien KS, Zhong L, Chow ED, Zhou Z, Cummings SL et al..  2018.  Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial.. Open Forum Infect Dis. 5(8):ofy182.